Related Experiment Video
Updated: Oct 23, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Contemporary use of anticoagulation in the cardiac catheterization laboratory: a review
Brent J Klinkhammer1, Sandeep Nathan2, Ankitkumar K Patel1
1Section of Cardiology, Hackensack University Medical Center, Hackensack, New Jersey.
Insights
This review examines clinical trials and guidelines for anticoagulation during percutaneous coronary interventions (PCI). It discusses drug pharmacokinetics and future directions for anticoagulation therapy in coronary artery disease.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Anticoagulation is crucial for percutaneous coronary interventions (PCI).
- Clinical trials have shaped current anticoagulation practices.
- Optimizing anticoagulation improves patient outcomes and procedural safety.
Purpose of the Study:
- To review significant clinical trials and guidelines for anticoagulation in the catheterization laboratory.
- To discuss the pharmacological aspects and pharmacokinetics of commonly used anticoagulation agents.
- To explore future directions in anticoagulation therapy for coronary artery disease.
Main Methods:
- Review of landmark clinical trials.
- Analysis of current clinical practice guidelines.
- Discussion of pharmacokinetic properties of anticoagulants.
Main Results:
- Established evidence base for anticoagulation in PCI.
- Identification of specific scenarios where anticoagulation may not be needed.
- Understanding of how pharmacokinetic parameters influence agent selection and monitoring.
Conclusions:
- Anticoagulation choice impacts PCI outcomes.
- Pharmacokinetic knowledge is essential for safe and effective anticoagulation.
- Future research will refine anticoagulation strategies in coronary artery disease.
Abstract:
Anticoagulation during percutaneous coronary interventions has a rich history that has been shaped by several key clinical trials. The correct choice of anticoagulation during interventions can maximize patient outcomes and ensure a safe procedure. However, in some specific situations, anticoagulation may not be required at all. In this review article, we review the significant clinical trials and current guidelines regarding the use of anticoagulation in the catheterization laboratory and discuss the unique pharmacological aspects of the most commonly used agents, with an emphasis on the specific pharmacokinetic parameters that dictate how these agents are used and monitored. Finally, we discussed the future directions in anticoagulation therapy in coronary artery disease. This review serves as a robust synopsis of the clinical data for practicing clinicians and fellows in training.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization III: Left Heart Catheterization
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiac Catheterization IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care

